Differences in biological age and blood biomarkers among non-hospitalised adults with long COVID: Supplementary material

Supplementary Table 1 : Baseline characteristics table for patients without persistent symptoms of long COVID (reference group) and patients with distinct persistent symptom phenotypes Supplementary Table 2: Selected blood biomarkers, estimated biological age, and chronological age at baseline (within 3 years prior to COVID-19) for patients without persistent symptoms of long COVID (reference group) and patients with distinct persistent symptom phenotypes Supplementary Table 3: Selected blood biomarkers, chronological age, and estimated biological age twelve or more weeks after COVID-19 diagnosis for patients without persistent symptoms of long COVID (reference group) and patients with distinct persistent symptom phenotypes Supplementary Table 4: Other blood biomarkers recorded twelve or more weeks after COVID-19 diagnosis for patients without persistent symptoms of long COVID and patients with distinct persistent symptom phenotypes Supplementary Table 5: Linear regression model assessing the association between long COVID phenotype and the difference between biological and chronological age, after adjusting for age, sex, ethnicity, socioeconomic, deprivation, body mass index, and smoking status